| 2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- |
2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- |
1237168-58-9 |
| Tubastatin-A |
TUBASTATIN A |
1252003-15-8 |
| 4-AMino-2-(trifluoroMethoxy)benzenesulfonaMide |
4-AMino-2-(trifluoroMethoxy)benzenesulfonaMide |
1261724-58-6 |
| N-(2-chloro-4-formyl-5-methoxyphenyl)acrylamide |
N-(2-chloro-4-formyl-5-methoxyphenyl)acrylamide |
1251456-87-7 |
| hexyl aMino(4-aMinophenyl)MethylenecarbaMate hydrochloride |
达比加群酯中间体4 |
1307233-93-7 |
| GLPG0187 |
GLPG0187, 一种广谱的INTEGRIN受体拮抗剂,具有抗肿瘤活性 |
1320346-97-1 |
| 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazole-2-carbaldehyde |
4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazole-2-carbaldehyde |
1352609-91-6 |
| 1,3-Dibromo-5-fluoro-4-methoxy-6-methyl-2-nitrobenzene |
1,3-二溴-2-硝基-4-甲氧基-5-氟-6-甲基苯 |
1357103-68-4 |
| E-7046 |
E-7046 |
1369489-71-3 |
| 4,6-Dibromo-2-fluoro-3-methylphenol |
2-氟-3-甲基-4,6-二溴苯酚 |
1357103-65-1 |
| 1,5-Dibromo-3-fluoro-2-methoxy-4-methylbenzene |
1,5-二溴-2-甲氧基-3-氟-4-甲基苯 |
1357103-67-3 |
| 2-PyridinaMine, 5-(1H-tetrazol-5-yl)- |
5-(2H-1,2,3,4-四唑-5-基)吡啶-2-胺 |
13566-35-3 |
| 2,4-Imidazolidinedione, 5-[[4-[4-hydroxy-3-(1-methylethyl)phenoxy]-3,5-diiodophenyl]methyl]- |
2,4-Imidazolidinedione, 5-[[4-[4-hydroxy-3-(1-methylethyl)phenoxy]-3,5-diiodophenyl]methyl]- |
1370363-74-8 |
| Dabigatran Etexilate N-Oxide |
达比加群酯杂质M |
1381757-44-3 |
| SC-43 |
SC-43 |
1400989-25-4 |
| 2-AMinopyrazolo[1,5-a]pyriMidine-3-carboxylic acid |
2-氨基吡唑并[1,5-A]嘧啶-3-甲酸 |
1394003-86-1 |
| 5-BroMo-3-Methylpyridine-2-carboxaMide |
5-BroMo-3-Methylpyridine-2-carboxaMide |
1400645-41-1 |
| Dabigatran Etexilate iMpurity C5 |
Dabigatran Etexilate iMpurity C5 |
1416446-45-1 |
| Dabigatran Impurity p |
达比加群酯杂质F |
1408238-37-8 |
| Dabigatran Impurity 38 |
达比加群杂质38 |
1416446-40-6 |
